45 filings
8-K
KYMR
Kymera Therapeutics Inc
2 May 24
Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update
7:10am
8-K
KYMR
Kymera Therapeutics Inc
1 Apr 24
Departure of Directors or Certain Officers
7:00am
8-K
KYMR
Kymera Therapeutics Inc
22 Feb 24
Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
7:10am
8-K
KYMR
Kymera Therapeutics Inc
5 Jan 24
Kymera Therapeutics Announces Proposed Public Offering
4:11pm
8-K
KYMR
Kymera Therapeutics Inc
4 Jan 24
Regulation FD Disclosure
4:01pm
8-K
9tcsifneb ao
4 Jan 24
STAT6 oral degrader KT-621, with dupilumab-like activity, expected to enter Phase 1 clinical trial in the second half of 2024
7:08am
8-K
hql7iduf0r 9h
2 Nov 23
Kymera Therapeutics to Present New Clinical Data from the Phase 1 Trial of STAT3 Degrader KT-333 at the ASH Annual Meeting
9:15am
8-K
hxk 1j2w0w74
2 Nov 23
Kymera Therapeutics Announces Third Quarter 2023 Financial Results and Provides a Business Update
7:10am
8-K
pyfp2 t3np2je3
3 Aug 23
Kymera Therapeutics Announces Second Quarter 2023 Financial Results and Provides a Business Update
7:10am
8-K
kmxyq
16 Jun 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
iya3mirzfn00a
22 May 23
Kymera Appoints Jeremy Chadwick, Ph.D., as Chief Operating Officer
4:45pm
8-K
ezqdycdpyr7sr
4 May 23
Kymera Therapeutics Announces First Quarter 2023 Financial Results and Provides a Business Update
7:10am
8-K
74kcsknoq1w
10 Mar 23
Regulation FD Disclosure
5:30pm
8-K
6a94j3j
27 Feb 23
Departure of Directors or Certain Officers
5:22pm
8-K
idj9ixi9ni7d
23 Feb 23
Kymera Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides a Business Update
7:11am
8-K
uxc99
10 Jan 23
Kymera Therapeutics Shares Key 2023 Goals to Support its Evolution
7:06am
8-K
r8156i6z
14 Dec 22
Regulation FD Disclosure
9:27am
8-K
irmx6g
14 Dec 22
Regulation FD Disclosure
7:16am
8-K
crw1wda78hiqxcxaif3
3 Nov 22
Kymera Therapeutics Announces Third Quarter 2022 Financial Results and Provides a Business Update
7:17am
8-K
dclnum6r 5wnys
13 Oct 22
Regulation FD Disclosure
4:36pm